Stay updated on Nivolumab in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Version upgraded to v3.0.2; the Back to Top element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T09:48:59.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T07:40:17.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a new facility name and location in Montreal, Quebec, Canada, along with expanded drug information for several agents. Notably, previous drug information has been removed, indicating a shift in focus or available treatments.
    Difference
    2%
    Check dated 2025-08-31T01:00:21.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page has removed the phrase 'Last Update Posted (Estimated)' and replaced it with 'Last Update Posted'.
    Difference
    0.0%
    Check dated 2025-08-23T21:54:56.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page has been updated to reflect new dates and a revision change, indicating a transition to version 2.16.12 from 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-16T19:58:57.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-09T15:18:59.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.